Search Results - "Lima, Helena Flávia Cuba de Almada"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Successful treatment with alectinib after crizotinib-induced hepatitis in ALK-rearranged advanced lung cancer patient: a case report by Duarte, Flávia Amaral, Rodrigues, Leonardo Brand, Paes, Flávia Rocha, Diniz, Paulo Henrique Costa, Lima, Helena Flávia Cuba de Almada

    Published in BMC pulmonary medicine (28-01-2021)
    “…Besides the clinical benefit of crizotinib in ALK-rearranged metastatic non-small cell lung cancer (NSCLC), concerns about its hepatotoxicity have arisen. It…”
    Get full text
    Journal Article
  2. 2